Value-based assessment of implementing a Pulmonary Embolism Response Team (PERT)

J Thromb Thrombolysis. 2021 Jan;51(1):217-225. doi: 10.1007/s11239-020-02188-3.

Abstract

PERTs are a new, multidisciplinary approach to PE care. They were conceived to efficiently identify and risk stratify PE patients and standardize care delivery. More research needs to be conducted to assess the effects that PERTs have had on PE care. This study sought to determine the effects of a PERT on quality and overall value of care. This was a retrospective study of all patients 18 years of age or older who presented with a principal diagnosis of an acute PE based on available ICD codes from January 1, 2010 to December 31, 2018. Patients who did not have an imaging study, i.e., CTPA or ECHO, available were excluded. Patients were divided into pre- (before October 2015) and post-PERT eras (after October 2015) and stratified based on the presence of right heart strain/dysfunction on imaging. All quality outcomes were extracted from the EMR, and cost outcomes were provided by the financial department. 530 individuals (226 pre-PERT and 304 post-PERT) were identified for analysis. Quality outcomes improved between the eras; most notably in-hospital mortality decreased (16.5 vs. 9.6) and hospital LOS decreased (7.7 vs. 4.4) (p < 0.05). Total cost of care also decreased a statistically significant amount between the eras. The implementation of a PERT improved quality and cost of care, resulting in improved value. We hypothesize that this may be due to more timely identification and risk stratification leading to earlier interventions and streamlined decision making, but further research is required to validate these findings in larger cohorts.

Keywords: Cost analysis; PE; PERT; Risk stratification; Value.

MeSH terms

  • Adult
  • Aged
  • Delivery of Health Care / economics
  • Hospital Mortality
  • Humans
  • Middle Aged
  • Patient Care Team / economics
  • Prognosis
  • Pulmonary Embolism / diagnosis*
  • Pulmonary Embolism / economics
  • Pulmonary Embolism / mortality
  • Retrospective Studies
  • Risk Assessment* / economics